TG THERAPEUTICS, INC. (TGTX) › Capital ExpendituresTG THERAPEUTICS, INC. (TGTX) — Capital ExpendituresAnnual figures by period end, from SEC filings.2011-12-31: $02012-12-31: $1.4K2013-12-31: $5.7K2014-12-31: $18.6K2015-12-31: $42.2K2016-12-31: $344.0K2017-12-31: $2.0K2018-12-31: $90.0K2019-12-31: $131.0K2020-12-31: $357.0K2021-12-31: $401.0K2022-12-31: $14.0K2023-12-31: $02024-12-31: $45.0K2025-12-31: $214.0K$214.0K2011-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$214.0K+375.6%2026-02-27From 2025-01-012024-12-31$45.0K—2026-02-27From 2024-01-012023-12-31$0-100.0%2026-02-27From 2023-01-012022-12-31$14.0K-96.5%2025-03-03From 2022-01-012021-12-31$401.0K+12.3%2024-02-29From 2021-01-012020-12-31$357.0K+172.5%2023-03-01From 2020-01-012019-12-31$131.0K+45.6%2022-03-01From 2019-01-012018-12-31$90.0K+4400.0%2021-03-01From 2018-01-012017-12-31$2.0K-99.4%2020-03-02From 2017-01-012016-12-31$344.0K+714.8%2019-03-01From 2016-01-012015-12-31$42.2K+127.3%2018-03-15From 2015-01-012014-12-31$18.6K+226.9%2017-03-16From 2014-01-012013-12-31$5.7K+306.1%2016-03-15From 2013-01-012012-12-31$1.4K—2014-03-07From 2012-01-012011-12-31$0—2013-03-21From 2011-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)